Ra Capital Management, L.P. Eledon Pharmaceuticals, Inc. Transaction History
Ra Capital Management, L.P.
- $4.82 Billion
- Q1 2025
A detailed history of Ra Capital Management, L.P. transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 3,566,338 shares of ELDN stock, worth $12.2 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
3,566,338
Previous 3,566,338
-0.0%
Holding current value
$12.2 Million
Previous $14.6 Million
17.12%
% of portfolio
0.25%
Previous 0.24%
Shares
1 transactions
Others Institutions Holding ELDN
# of Institutions
87Shares Held
37.2MCall Options Held
10.5KPut Options Held
66.8K-
Bvf Inc San Francisco, CA6.29MShares$21.5 Million0.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$10.1 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN2.33MShares$7.96 Million1.01% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.31MShares$7.89 Million2.06% of portfolio
-
Blue Owl Capital Holdings LP New York, NY1.82MShares$6.22 Million3.19% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $47M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...